Insider trade

Director sold ~$496K of UTHR shares in the open market

Traded Dec 15, 2025 · Filed Dec 17, 2025

Why it stands out

A United Therapeutics director sold $496K of United Therapeutics shares. The filing does not indicate a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$100K–$500K

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$495,954

Shares × reported transaction price

Timing vs results

47 days after results of Oct 29, 2025, 72 days before results of Feb 25, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

This transaction was executed in multiple trades at prices ranging from $495.64 to $496.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filed 9mo ago

Traded Jan 15 · filed 1 day later

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceFiled 9mo ago

Scheduled in advanceFiled 9mo ago